YDES
NASDAQ · Biotechnology
Yd Bio Ltd
$5.31
+0.02 (+0.35%)
Financial Highlights (FY 2026)
Revenue
559.7K
Net Income
-1,554,849
Gross Margin
30.4%
Profit Margin
-276.6%
Rev Growth
—
D/E Ratio
0.01
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 30.4% | 43.0% | 43.0% | 43.0% |
| Operating Margin | -286.4% | 23.0% | 23.0% | 20.8% |
| Profit Margin | -276.6% | 23.8% | 21.7% | 19.2% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 559.7K | 122.20M | 119.09M | 134.19M |
| Gross Profit | 170.4K | 52.52M | 51.18M | 57.67M |
| Operating Income | -1,603,389 | 28.12M | 27.40M | 27.90M |
| Net Income | -1,554,849 | 29.08M | 25.78M | 25.78M |
| Gross Margin | 30.4% | 43.0% | 43.0% | 43.0% |
| Operating Margin | -286.4% | 23.0% | 23.0% | 20.8% |
| Profit Margin | -276.6% | 23.8% | 21.7% | 19.2% |
| Rev Growth | — | +2.9% | +5.6% | -10.0% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 1.06M | 239.43M | 188.25M | 198.79M |
| Total Equity | 185.52M | 534.41M | 574.88M | 548.17M |
| D/E Ratio | 0.01 | 0.45 | 0.33 | 0.36 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -1,531,526 | 41.35M | 38.15M | 43.54M |
| Free Cash Flow | — | 33.20M | 25.74M | 34.14M |